Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06660017 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jun 2026 to Sep 2026v3
  2. Primary completion date: Nov 2026 to Jun 2027
    • Start date: Nov 2024 to Jun 2026
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This 2-arm phase II study proposes to determine the efficacy of ketamine oral rinse in pain relief from mucositis in head and neck cancer patients undergoing radiation treatment.
Trial Details
NCT Number NCT06660017
Lead Sponsor University of Oklahoma
Conditions
(from sponsor)		 Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 62 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov